Ingenix Raises Euro13m From Sofinnova Partners-Led Syndicate to Scale Modality Fusion, a Novel Architecture for Drug Development
WARSAW, Poland, June 03 — Ingenix, the AI and biology company built around a single question – “What would it take for AI to truly understand biology?” – has today announced a €13m seed-extension…
